Buprenorphine reduces methamphetamine intake and drug seeking behavior via activating nociceptin/orphanin FQ peptide receptor in rats

Buprenorphine, which has been approved for the treatment of opioid dependence, reduces cocaine consumption by co-activating μ-opioid receptors and nociceptin/orphanin FQ peptide (NOP) receptors. However, the role of buprenorphine in methamphetamine (METH) reinforcement and drug-seeking behavior rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fangmin, Shen, Wenwen, Cai, Yujia, Zhang, Xin, Du, Han, Lai, Miaojun, Liu, Huifen, Kohli, Evelyne, Zhou, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583165/
https://www.ncbi.nlm.nih.gov/pubmed/36276332
http://dx.doi.org/10.3389/fpsyt.2022.983595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583165/
https://www.ncbi.nlm.nih.gov/pubmed/36276332
http://dx.doi.org/10.3389/fpsyt.2022.983595

Ejemplares similares